BEONE MEDICINES LTD. (ONC) Current Ratio
- Current ratio · latest quarter: Value 3.40×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 3.40× | Current assets / current liabilities. $7.22B ÷ $2.12B ≈ 3.40× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 7.22B USD | Assets, Current |
| Current obligations | 2.12B USD | Liabilities, Current |
| Cash and equivalents | 5.10B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | 1.06B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 732.60M USD | Inventory, Net |
| Payables | 470.30M USD | Accounts Payable, Current |
| Borrowing debt due within one year | 190.90M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.22B | $2.12B | $5.10B | (m) | $1.06B | $732.60M | $470.30M | $190.90M | 3.40× |
| 2026-03-31 | $6.60B | $1.81B | $4.79B | (m) | $938.02M | $681.59M | $423.55M | $116.14M | 3.64× |
| 2025-12-31 | $6.23B | $1.83B | $4.55B | (m) | $865.08M | $608.23M | $479.04M | $57.29M | 3.41× |
| 2025-09-30 | $5.66B | $2.37B | $4.04B | (m) | $863.28M | $531.69M | $383.68M | (m) | 2.39× |
| 2025-06-30 | $4.31B | $2.21B | $2.76B | (m) | $770.78M | $502.87M | $360.78M | $808.39M | 1.95× |
| 2025-03-31 | $3.90B | $1.98B | $2.52B | (m) | $717.24M | $494.66M | $364.50M | $763.47M | 1.96× |
| 2024-12-31 | $3.99B | $2.21B | $2.63B | (m) | $676.28M | $494.99M | $405.00M | $851.53M | 1.80× |
| 2024-09-30 | $3.91B | $2.03B | $2.70B | (m) | $569.05M | $431.68M | $307.53M | $863.80M | 1.93× |
| 2024-06-30 | $3.84B | $1.94B | $2.59B | (m) | $529.45M | $443.26M | $333.02M | $851.66M | 1.98× |
| 2024-03-31 | $3.91B | $1.88B | $2.79B | (m) | $435.29M | $447.35M | $356.57M | $826.97M | 2.08× |
| 2023-12-31 | $4.20B | $1.81B | $3.17B | (m) | $358.03M | $416.12M | $315.11M | $688.37M | 2.32× |
| 2023-09-30 | $4.05B | $1.28B | $3.07B | (m) | $309.08M | $316.93M | $341.86M | $328.56M | 3.16× |
| 2023-06-30 | $4.40B | $1.41B | $3.41B | (m) | $299.28M | $321.33M | $266.98M | $421.05M | 3.13× |
| 2023-03-31 | $4.70B | $1.25B | $3.54B | (m) | $309.63M | $297.00M | $241.36M | $281.81M | 3.75× |
| 2022-12-31 | $5.21B | $1.47B | $3.87B | (m) | $173.17M | $282.35M | $294.78M | $328.97M | 3.55× |
| 2022-09-30 | $5.75B | $1.41B | $4.20B | (m) | $189.17M | $290.91M | $252.07M | $441.27M | 4.07× |
| 2022-06-30 | $6.35B | $1.40B | $4.53B | (m) | $172.26M | $262.21M | $234.35M | $380.73M | 4.54× |
| 2022-03-31 | $6.95B | $1.38B | $4.35B | $1.90B | $190.80M | $245.63M | $236.91M | $407.39M | 5.05× |
| 2021-12-31 | $7.61B | $1.60B | $4.38B | (m) | $483.11M | $242.63M | $262.40M | $427.56M | 4.76× |
| 2021-09-30 | $4.43B | $1.30B | $1.38B | $2.53B | $129.58M | $150.98M | $206.20M | $442.37M | 3.40× |
| 2021-06-30 | $4.80B | $1.24B | $1.78B | $2.61B | $73.79M | $117.59M | $168.83M | $434.80M | 3.86× |
| 2021-03-31 | $5.14B | $1.11B | $1.90B | $2.91B | $84.01M | $72.97M | $146.92M | $405.05M | 4.62× |
| 2020-12-31 | $4.96B | $1.08B | $1.38B | $3.27B | $60.40M | $89.29M | $231.96M | $335.01M | 4.61× |
| 2020-09-30 | $4.97B | $645.72M | $1.46B | $3.25B | $60.27M | $35.52M | $146.26M | $50.22M | 7.69× |
| 2020-06-30 | $3.39B | $551.20M | $1.35B | $1.81B | $61.66M | $33.23M | $157.17M | $26.06M | 6.15× |
| 2020-03-31 | $3.60B | $451.80M | $1.96B | $1.42B | $65.62M | $28.77M | $98.36M | $11.30M | 7.96× |
| 2019-12-31 | $1.17B | $310.31M | $618.01M | $364.73M | $70.88M | $28.55M | $122.49M | $0.00 | 3.78× |
| 2019-09-30 | $1.44B | $265.73M | $856.15M | (m) | $55.91M | $37.51M | $112.28M | $700.00K | 5.40× |
| 2019-06-30 | $1.76B | $271.68M | $918.95M | (m) | $58.11M | $49.05M | $148.54M | $8.74M | 6.46× |
| 2019-03-31 | $1.80B | $238.81M | $764.49M | (m) | $58.98M | $13.14M | $105.32M | $8.94M | 7.52× |
| 2018-12-31 | $1.94B | $246.45M | $712.94M | $1.07B | $41.06M | $16.24M | $113.28M | $8.73M | 7.89× |
| 2018-09-30 | $2.18B | $188.42M | $643.49M | (m) | $37.37M | $19.70M | $85.55M | $8.74M | 11.57× |
| 2018-06-30 | $1.52B | $186.44M | $438.42M | (m) | $33.17M | $6.32M | $85.88M | $9.07M | 8.14× |
| 2018-03-31 | $1.59B | $141.90M | $490.63M | (m) | $23.48M | $7.50M | $52.72M | $9.56M | 11.18× |
| 2017-12-31 | $913.50M | $149.99M | $239.60M | (m) | $29.43M | $10.93M | $69.78M | $9.22M | 6.09× |
| 2017-09-30 | $962.33M | $103.16M | $208.51M | $498.86M | $10.52M | $5.71M | $35.17M | $9.02M | 9.33× |
| 2017-06-30 | $418.69M | $49.95M | $261.01M | $146.42M | (m) | (m) | $24.42M | (m) | 8.38× |
| 2017-03-31 | $336.18M | $49.98M | $97.75M | $229.73M | (m) | (m) | $20.48M | (m) | 6.73× |
| 2016-12-31 | $374.40M | $35.06M | $87.51M | (m) | (m) | (m) | $11.96M | (m) | 10.68× |
| 2016-09-30 | $209.95M | $29.32M | $85.53M | $118.09M | (m) | (m) | $7.31M | (m) | 7.16× |
| 2016-06-30 | $232.75M | $20.46M | $58.08M | $168.53M | (m) | (m) | $6.07M | (m) | 11.37× |
| 2016-03-31 | $251.78M | $15.83M | $208.51M | $38.72M | (m) | (m) | $3.82M | (m) | 15.91× |
| 2015-12-31 | $106.27M | $35.17M | $17.87M | $82.62M | (m) | (m) | $8.98M | (m) | 3.02× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.